National Medical Care Reports SAR 146.43M Net Profit in the Six Months 2026
CARE 4005.SA | 0.00 |
On 2026-07-30 15:44:00 (Saudi Time), National Medical Care Company announced its Interim financial results for the six months ended on June 30, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 456,351 | 397,872 | 14.697 | 387,992 | 17.618 |
| Gross Profit (Loss) | 169,089 | 147,483 | 14.649 | 122,652 | 37.86 |
| Operational Profit (Loss) | 106,754 | 84,979 | 25.623 | 62,983 | 69.496 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 93,972 | 79,941 | 17.551 | 52,459 | 79.134 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 93,972 | 79,941 | 17.551 | 52,459 | 79.134 |
| All figures are in (Thousands) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 844,343 | 783,193 | 7.807 |
| Gross Profit (Loss) | 291,740 | 290,461 | 0.44 |
| Operational Profit (Loss) | 169,737 | 182,175 | -6.827 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 146,431 | 165,306 | -11.418 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 146,431 | 165,306 | -11.418 |
| Total Shareholders Equity (after Deducting Minority Equity) | 1,862,884 | 1,701,966 | 9.454 |
| Profit (Loss) per Share | 3.28 | 3.7 | |
| All figures are in (Thousands) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| Accumulated Losses | - | - | |
| All figures are in (Thousands) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
For the six-month period ending 30 June 2026, sales/revenue rose 7.807% YoY to SAR 844.34 million (from SAR 783.19 million), driven by a 15.3% increase in total patient volumes, sustained momentum across key payor segments, and broad-based contributions across the Group's hospital network led by Al Malaz with additional gains at Al Rawabi, Al Salam, Al Haram and ReLib. However, net profit attributable to shareholders declined 11.418% YoY to SAR 146.43 million (from SAR 165.31 million), with net profit margin contracting to 17.3% from 21.1%, as a 12.2% increase in cost of revenue outpaced top-line growth, compounded by a 12.7% rise in operating expenses primarily reflecting higher SG&A costs associated with expanded operations and increased finance costs during the period.
Quarter-on-Quarter Performance Drivers
QoQ revenue rose 17.618% to SAR 456.35 million (converted: SAR 456.35 million) from SAR 387.99 million in the prior quarter, driven by an 11.3% increase in patient volumes as activity normalized following the seasonal slowdown associated with Ramadan and Eid, alongside a recovery in payer mix. Net profit surged 79.134% QoQ to SAR 93.97 million from SAR 52.46 million in Q1 2026, primarily reflecting strong revenue growth, a 37.86% increase in gross profit with gross margin recovering to 37.1% from 31.6%, and improved operating profitability supported by lower expected credit loss (ECL) provisions and higher operating income during the quarter.
Other Items
Unmodified conclusion was issued by the external auditor with no additional comments, reservations, or other matters noted. No accumulated losses were reported. The external auditor's report contained no emphasis of matter, qualification, disclaimer, or adverse opinion paragraphs.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=97101&anCat=1&cs=4005&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/6526_436_2026-07-30_14-04-36_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.